A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma

NCT00498043 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

222

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, B-Cell
Lymphoma, Large-Cell, Diffuse

Interventions

DRUG: R-CHOP14 induction regimen
DRUG: R-ACVBP14 induction regimen

Sponsor

Hospices Civils de Lyon